SEI Investments’s Aratana Therapeutics, Inc. PETX Stock Holding History

SEI Investments’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,664	Closed	-$41K	–	3038
2018 Q4	$41K	Buy	+6,664	New	+$40.7K	﹤0.01%	2388
2017 Q4	–	Sell	-2	Closed	–	–	3596
2017 Q3	$0	Hold	2	–	–	﹤0.01%	3506
2017 Q2	$0	Buy	+2	New	+$12	﹤0.01%	3390
2017 Q1	–	Sell	-145	Closed	-$1K	–	3165
2016 Q4	$1K	Hold	145	–	–	﹤0.01%	2868
2016 Q3	$1K	Buy	+145	New	+$1.2K	﹤0.01%	2788
2016 Q1	–	Sell	-464	Closed	-$3K	–	2725
2015 Q4	$3K	Buy	464 +168	+57%	+$1.11K	﹤0.01%	2361
2015 Q3	$3K	Buy	+296	New	+$5.01K	﹤0.01%	2342

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

SEI Investments's PETX Position: Q1 2019 in Review

SEI Investments sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 6,664 shares — an estimated $41K sold.

SEI Investments first reported a position in PETX in Q3 2015 and held it in 7 quarters. The position peaked at $41K in Q4 2018. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

SEI Investments reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
SEI Investments sold 6,664 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $41K.
SEI Investments first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
SEI Investments's Aratana Therapeutics, Inc. position peaked at $41K in Q4 2018.
104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on SEI Investments's 13F filing for Q1 2019, filed 15 May 2019.